![Bruno Oesch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Bruno Oesch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Vorsitzender | 01.01.2005 | - |
Gründer | 01.01.2005 | - | |
Corporate Officer/Principal | 18.07.2012 | - | |
Präsident | 04.11.2009 | 18.07.2012 | |
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Direktor/Vorstandsmitglied | 01.05.2010 | - |
Vorstandsvorsitzender | 01.05.2010 | - | |
Gründer | 01.05.2010 | - |
Karriereverlauf von Bruno Oesch
Ehemalige bekannte Positionen von Bruno Oesch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | - | - |
Prionics AG
![]() Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Vorsitzender | 04.11.2009 | - |
Technik-/Wissenschafts-/F&E-Leiter | 04.11.2009 | 03.05.2011 | |
Gründer | 27.02.1997 | - | |
Präsident | 04.11.2009 | 03.05.2011 |
Ausbildung von Bruno Oesch
Swiss Federal Institute of Technology | Graduate Degree |
University of Zurich | Doctorate Degree |
Statistik
International
Schweiz | 5 |
Deutschland | 2 |
Vereinigte Staaten | 2 |
Operativ
Founder | 3 |
Chairman | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Neurotune AG
![]() Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Prionics AG
![]() Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |
Malcisbo AG
![]() Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Börse
- Insiders
- Bruno Oesch
- Erfahrung